Indications

Cardiovascular Diseases

1. April 2016
Petra Kowalski

30+ clinical sites in Bulgaria, Germany, Poland
30+ investigators in cardiology

Severe Heart Failure

phase III trials in 200 patients

Ischaemic Heart Disease

phase III trial